ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMHD HLK Biotech Holding Group Inc (CE)

0.0002
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
HLK Biotech Holding Group Inc (CE) USOTC:AMHD OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.00 00:00:00

Amelot Holdings Inc. Announces the Formation of a New Subsidiary in Trinidad and Tobago, and Additional Share Purchases in the O

19/01/2010 2:24pm

Marketwired


HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more HLK Biotech (CE) Charts.

Amelot Holdings, Inc. (PINKSHEETS: AMHD) today announced that its wholly owned subsidiary, Amelot Oil Inc., has retained the legal services of C.A. Serrano & Co, Attorneys-at-Law, to begin the formation of a new subsidiary to be located in Trinidad and Tobago.

In order to set up a fully automated large scale biodiesel production facility in Trinidad and Tobago an upcoming trip to Europe to meet with a major equipment manufacturer is scheduled for early February 2010. The formation of a subsidiary at this time will facilitate in establishing future business relationships there.

"Our aim is to launch our activities in Trinidad and Tobago by using European technology in the production of biodiesel, for which there is increasing demand among the consumers in the Caribbean. We will be releasing further updates as events unfold. These are exciting times for all of us at Amelot and we again thank you for your continued support and patience," said Fred Guarnieri, President and CEO.

The current Outstanding Common Shares balance is 4,309,573,155 and the Authorized is 4,925,000,000. Mr. Guarnieri currently owns 693,975,000 shares of the Company's common stock. He has purchased 28,375,000 since December 31, 2009 in the open market through his on line brokerage accounts. He has neither sold, pledged, assigned or transferred any of his purchased shares of the Company since becoming President in June 2009. There have been no issuances of additional shares since August 2008.

About Amelot Holdings, Inc. (PINKSHEETS: AMHD):

Amelot Holdings, Inc. (http://www.amelotholdings.com), a publicly traded company, is a diversified holding company that has identified Biodiesel as a multi-billion emerging Biofuel market. Amelot plans to have a significant market share in growing low cost feedstocks to supply the growing demand for biodiesel, to reduce energy dependency of fossil fuels, to help reduce the U.S. dependency on foreign oil supplies and reduce the impact of energy on our environment.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

Contact: Amelot Holdings, Inc. 1(866)-669-8373 support@amelotholdings.com http://www.amelotholdings.com

1 Year HLK Biotech (CE) Chart

1 Year HLK Biotech (CE) Chart

1 Month HLK Biotech (CE) Chart

1 Month HLK Biotech (CE) Chart

Your Recent History

Delayed Upgrade Clock